s****p
发帖数: 1087 | 1 偶然翻到关于可以接受的重复发表类似研究成果的条款
其中提到这一款：
3. The paper for secondary publication is intended for a different group of
readers; an abbreviated version could be sufficient.
顺便问个问题，我的论文A发表了。我论文B是基于论文A进一步的一个小问题研究，所
以要介绍一下论文A。那么最好的介绍当然是用图啦。
我可以直接采用在论文A上发表的图吗？
好像听说不可以？或者要得到杂志同意？
哪里去找相关条款呀？
**********************************************************
http://www.icmje.org/publishing_4overlap.html
Uniform Requirements for Manuscripts Submitted to Biomedical Journals:
Publishing and Editorial Issues Related to Publication in Biomedical
Journals: Overlapping Publications
Duplicate Submission
Most biomedical journals will not consider manuscripts that are
simultaneously being considered by other journals. Among the principal
considerations that have led to this policy are: 1) the potential for
disagreement when two (or more) journals claim the right to publish a
manuscript that has been submitted simultaneously to more than one; and 2)
the possibility that two or more journals will unknowingly and unnecessarily
undertake the work of peer review, edit the same manuscript, and publish
the same article.
However, editors of different journals may decide to simultaneously or
jointly publish an article if they believe that doing so would be in the
best interest of public health.
Redundant Publication
Redundant (or duplicate) publication is publication of a paper that overlaps
substantially with one already published in print or electronic media.
Readers of primary source periodicals, whether print or electronic, deserve
to be able to trust that what they are reading is original unless there is a
clear statement that the author and editor are intentionally republishing
an article. The bases of this position are international copyright laws,
ethical conduct, and cost-effective use of resources. Duplicate publication
of original research is particularly problematic because it can result in
inadvertent double-counting or inappropriate weighting of the results of a
single study, which distorts the available evidence.
Most journals do not wish to receive papers on work that has already been
reported in large part in a published article or is contained in another
paper that has been submitted or accepted for publication elsewhere, in
print or in electronic media. This policy does not preclude the journal from
considering a paper that has been rejected by another journal, or a
complete report that follows publication of a preliminary report, such as an
abstract or poster displayed at a professional meeting. It also does not
prevent journals from considering a paper that has been presented at a
scientific meeting but was not published in full, or that is being
considered for publication in a proceedings or similar format. Brief press
reports of scheduled meetings are not usually regarded as breaches of this
rule, but they may be if additional data or copies of tables and figures
amplify such reports. The ICMJE does not consider results posted in clinical
trial registries as previous publication if the results are presented in
the same, ICMJE-accepted registry in which initial registration of trial
methods occurred and if the results are posted in the form of a brief
structured abstract or table. The ICMJE also believes that the results
registry should either cite full publications of the results when available
or include a statement that indicates that the results have not yet been
published in a peer-reviewed journal.
When submitting a paper, the author must always make a complete statement to
the editor about all submissions and previous reports (including meeting
presentations and posting of results in registries) that might be regarded
as redundant or duplicate publication. The author must alert the editor if
the manuscript includes subjects about which the authors have published a
previous report or have submitted a related report to another publication.
Any such report must be referred to and referenced in the new paper. Copies
of such material should be included with the submitted manuscript to help
the editor decide how to handle the matter.
If redundant or duplicate publication is attempted or occurs without such
notification, authors should expect editorial action to be taken. At the
least, prompt rejection of the submitted manuscript should be expected. If
the editor was not aware of the violations and the article has already been
published, then a notice of redundant or duplicate publication will probably
be published with or without the author’s explanation or approval.
Preliminary reporting to public media, governmental agencies, or
manufacturers of scientific information described in a paper or a letter to
the editor that has been accepted but not yet published violates the
policies of many journals. Such reporting may be warranted when the paper or
letter describes major therapeutic advances or public health hazards, such
as serious adverse effects of drugs, vaccines, other biological products,
medicinal devices, or reportable diseases. This reporting should not
jeopardize publication, but should be discussed with and agreed upon by the
editor in advance.
Acceptable Secondary Publication
Certain types of articles, such as guidelines produced by governmental
agencies and professional organizations, may need to reach the widest
possible audience. In such instances, editors sometimes deliberately publish
material that is also being published in other journals, with the agreement
of the authors and the editors of those journals. Secondary publication for
various other reasons, in the same or another language, especially in other
countries, is justifiable and can be beneficial provided that the following
conditions are met.
1. The authors have received approval from the editors of both journals (the
editor concerned with secondary publication must have a photocopy, reprint,
or manuscript of the primary version).
2. The priority of the primary publication is respected by a publication
interval of at least 1 week (unless specifically negotiated otherwise by
both editors).
3. The paper for secondary publication is intended for a different group of
readers; an abbreviated version could be sufficient.
4. The secondary version faithfully reflects the data and interpretations of
the primary version.
5. The footnote on the title page of the secondary version informs readers,
peers, and documenting agencies that the paper has been published in whole
or in part and states the primary reference. A suitable footnote might read:
“This article is based on a study first reported in the [title of journal,
with full reference].”
Permission for such secondary publication should be free of charge.
6. The title of the secondary publication should indicate that it is a
secondary publication (complete republication, abridged republication,
complete translation, or abridged translation) of a primary publication. Of
note, the NLM does not consider translations to be “republications” and
does not cite or index translations when the original article was published
in a journal that is indexed in MEDLINE.
7. Editors of journals that simultaneously publish in multiple languages
should understand that NLM indexes the primary language version. When the
full text of an article appears in more than one language in a journal issue
(such as Canadian journals with the article in both English and French),
both languages are indicated in the MEDLINE citation (for example, Mercer K.
The relentless challenge in health care. Healthc Manage Forum. 2008 Summer;
21(2):4-5. English, French. No abstract available. PMID:18795553. |
|
